Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Array BioPharma Inc.
Array BioPharma Receives $40 Million from Deerfield
January 10th, 2009
Array BioPharma Inc. (NASDAQ:ARRY) announced that it has received its second draw of $40 million from Deerfield Management, a leading healthcare investment organization and one of Array’s largest shareholders. Deerfield committed $80 million to Array in May 2008 and provided the first $40 million draw to Array in June 2008. Together with existing capital, these funds are being use to advance Array’s seven wholly owned small molecule drug programs in development. The $80 million interest-bearing loan is due in April 2014. Principal and unpaid interest may be prepaid in whole or in part at any time. Prepayment of principal and accrued compound interest may be made at the...
Source: Law & Health Weekly (2009-01-10)
|
